Search Login Register

palivizumab Summary

Also Known As: Abbott brand of palivizumab; MEDI 493; MEDI-493; MedImmune brand of palivizumab; Synagis Show All >>

Networked: 354 relevant articles (52 outcomes, 67 trials/studies) for this Drug

Key Diseases for which palivizumab is Relevant

  1. Infection : 29 outcomes 37 studies in 226 results
  2. Heart Diseases (Heart Disease) : 9 outcomes 8 studies in 65 results
  3. Bronchiolitis : 5 outcomes 6 studies in 32 results
  4. Lung Diseases (Lung Disease) : 4 outcomes 7 studies in 53 results
  5. Bronchopulmonary Dysplasia : 4 outcomes 5 studies in 31 results
Show All >>

Drugs Related to palivizumab

  1. palivizumab
  2. Neutralizing Antibodies
  3. human MEDI-524 monoclonal antibody (Numax)
  4. Oxygen
  5. Monoclonal Antibodies
  6. Nitrous Oxide (Laughing Gas)
  7. EMLA
  8. respiratory syncytial virus immune globulin intravenous
  9. Ribavirin (Virazole)
  10. Antibodies
Show All >>

Therapies Related to palivizumab

  1. Injections
  2. Intramuscular Injections
  3. Transplantation (Transplant Recipients)
  4. Transplants (Transplant)
  5. Artificial Respiration (Mechanical Ventilation)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.